$6.63
-0.44-6.22%
Last update: Nov 5, 7:49 PM
Avalo Therapeutics Inc (AVTX) Stock Price, Quote, News & History
AVTXNASDAQ
Avalo Therapeutics reported better-than-expected Q1 loss due to positive trial results. Analysts maintain Buy ratings with lowered price targets.
You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.
Other companies in Avalo Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Avalo Therapeutics has a consensus price target of $35.57.
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $6.6192 last updated November 5, 2026 at 7:49 PM EST.
There are no upcoming dividends for Avalo Therapeutics.
Avalo Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Avalo Therapeutics.
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"),...
